PROM1 and hepatocellular carcinoma: Isocorydine could not only significantly reduce the percentage of CD133+ and EpCAM-expressing cells, two types of cancer stem cells, but also could suppress the ability of primary liver carcinoma PLC/PRF/5 CD133+ cells to form hepatospheres and tumor-like spheres in vitro [9,10,11].